drugset / Trial / NCT01873625

Transplantation of Bone Marrow Derived Mesenchymal Stem Cells in Affected Knee Osteoarthritis by Rheumatoid Arthritis

NCT01873625

Phase 2/3 Completed 60 enrolled Royan Institute
RandomizedParallel-groupOpen-labelTreatment

Summary

Osteoarthritis of the knee is one of the most common causes of disability among elderly. Arthritis rheumatoid is an autoimmune disease which causes multi articular arthritis, such as knee osteoarthritis. As the disease progresses the cartilage become frustrated, surrounding bone react to become thicker and inflammation occurs in subchondral bone seen in T2-weighted MRI as increase in signal density. Patients are treated initially by pain management. In patients who don't response to first line treatment invasive treatment like total knee replacement is done. The investigators designed this clinical study with the aim of evaluating therapeutic effects of intra-articular injection of bone marrow mesenchymal stem cells (BM-MSCs) in 60 patients with knee osteoarthritis.

Timeline

Start
2009-10
Primary completion
2011-03
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator mesenchymal stem cells Cell therapy 4e+07 cells Other

Indications